Search this site

Explore neuroimaging with The Neurosurgical Case Room (TNCR), covering CT and MRI interpretation, imaging patterns and their application to neurosurgical diagnosis and clinical decision-making. Coming Soon.

Meet the team behind The Neurosurgical Case Room (TNCR), working together to build accessible, structured and globally connected neurosurgical education. The Team A global community of neurosurgeons, educators, and collaborators working together to advance neurosurgical education. About the Founder Background, journey and vision behind TNCR. The Team Meet the core team behind TNCR. TNCR Representatives Our representatives supporting TNCR’s global community.

Explore craniosynostosis with The Neurosurgical Case Room (TNCR), including classification, clinical assessment, imaging, surgical indications and principles of operative management. Craniosynostosis Craniosynostosis is the premature fusion of one or more cranial sutures, resulting in restricted skull growth perpendicular to the fused suture and compensatory overgrowth at unfused sutures. This produces abnormal skull morphology, may impair normal brain growth, and can lead to increased intracranial pressure. Craniosynostosis may be nonsyndromic or syndromic and may involve a single suture or multiple sutures. It affects skull shape, cranial volume, and in severe forms can cause ophthalmologic, respiratory, and neurocognitive complications. Q. What is the embryologic and pathophysiologic basis of craniosynostosis? Cranial sutures are mesenchymal growth plates that accommodate rapid brain expansion during infancy. Premature suture fusion results from abnormalities in dural signaling, mesenchymal ossification pathways, or genetic mutations affecting FGFR and TWIST pathways. Syndromic forms arise from mutations leading to enhanced osteogenesis, whereas simple monostutural cases are often idiopathic. Fusion restricts growth in one axis and forces compensatory growth in others, producing characteristic cranial deformities. Multisuture synostosis significantly decreases intracranial volume and predisposes to elevated ICP. Q. What is Virchow’s law and how does it apply to craniosynostosis? Virchow’s law states that premature fusion of a cranial suture restricts skull growth perpendicular to the fused suture and causes compensatory overgrowth parallel to it. This biomechanical principle explains the predictable skull shapes in each type of craniosynostosis. Sagittal synostosis: restricted parietal expansion, increased anteroposterior growth, producing dolichocephaly. Unicoronal synostosis: restricted anterior fossa expansion ipsilaterally, contralateral frontal bossing and orbital asymmetry. Metopic synostosis: restricted frontal expansion, trigonocephaly. Lambdoid synostosis: restricted posterior expansion, ipsilateral occipital flattening and ear displacement Q. What are the major etiological categories of craniosynostosis? Congenital and developmental: Idiopathic premature suture fusion Defective dural mesenchymal signaling Mutations in FGFR2, FGFR3, FGFR1, TWIST1, TCF12 (Crouzon, Apert, Pfeiffer, Saethre Chotzen, Muenke syndromes) Secondary causes: Intracranial hypotension from over shunting Postoperative scarring Teratogenic factors Metabolic disorders such as rickets Cranial base synostosis affecting skull growth vectors Approximately one quarter of cases are syndromic and often multisuture. Q. How is craniosynostosis classified? Craniosynostosis is categorized based on the specific fused suture: Sagittal synostosis: produces dolichocephaly or scaphocephaly Unicoronal synostosis: produces anterior plagiocephaly Bicoronal synostosis: produces brachycephaly, common in syndromes Metopic synostosis: produces trigonocephaly Lambdoid synostosis: produces posterior plagiocephaly Patterns may be isolated or part of syndromic complexes. Pansynostosis, involving all major sutures, produces the cloverleaf skull deformity. Q. What is sagittal synostosis and how does it present? Sagittal synostosis is the most common form, especially in males. Premature fusion of the sagittal suture restricts biparietal expansion, resulting in an elongated skull with frontal bossing and a prominent occiput. A midline sagittal ridge may be palpable. Intracranial pressure can be elevated in a minority of cases. Treatment within 3 to 6 months involves a strip craniectomy extending from the bregma to lambda or endoscopic assisted suturectomy followed by molding helmet therapy. Q. What is coronal synostosis and how does it present? Coronal synostosis may be unilateral or bilateral. Unilateral fusion produces anterior plagiocephaly with ipsilateral forehead flattening, contralateral frontal bossing, orbital asymmetry, and the harlequin eye sign on imaging. Bilateral fusion produces brachycephaly with a broad, flattened forehead and restricted anterior posterior skull growth. Coronal synostosis is common in syndromes such as Crouzon and Apert, often involving craniofacial abnormalities and orbital deformities. Surgical correction includes strip craniectomy or fronto orbital advancement. Q. What is metopic synostosis and how does it present? Metopic synostosis results from premature closure of the metopic suture and leads to trigonocephaly. Characteristic features include a midline frontal ridge, triangular forehead, hypotelorism, and constricted anterior fossa. This type accounts for less than 10 percent of cases and may be associated with cognitive impairment in some children. Surgical correction is typically indicated for moderate to severe deformity. Q. What is lambdoid synostosis and how is it differentiated from positional plagiocephaly? Lambdoid synostosis is rare. It produces posterior plagiocephaly characterized by occipital flattening, ear displacement inferiorly and posteriorly, and a rhomboid shaped skull. Positional plagiocephaly, by contrast, leads to anterior displacement of the ipsilateral ear and does not involve suture fusion. Management includes repositioning or molding helmets, with surgery reserved for severe cases. Positional plagiocephaly: Ipsilateral ear displaced anteriorly No palpable ridge Open sutures on imaging Parallelogram head shape Lambdoid synostosis: Ipsilateral ear displaced posteriorly and inferiorly Palpable lambdoid ridge Suture fused on CT Rhomboid skull shape Q. What is pansynostosis and how does it present? Pansynostosis involves fusion of multiple or all cranial sutures, producing the cloverleaf skull or turricephaly pattern. It is associated with severe craniofacial deformity, proptosis, bulging temporal regions, and risk of optic nerve compression. Intracranial pressure is frequently elevated. Management requires complex cranial vault expansion performed early in infancy. Q. What is the relationship between craniosynostosis and increased intracranial pressure? Intracranial pressure may rise due to reduced intracranial volume, impaired venous drainage, or associated hydrocephalus. Up to 50 percent of children with syndromic multisuture synostosis and 20 percent with nonsyndromic single suture synostosis exhibit increased ICP. Symptoms include headache, vomiting, irritability, papilledema, behavioral changes, and developmental delay. Venous hypertension from skull base synostosis or jugular foramen narrowing contributes significantly in syndromic cases. Q. Why does hydrocephalus occur in syndromic craniosynostosis? Hydrocephalus in syndromic craniosynostosis results from a combination of reduced intracranial volume, impaired venous outflow, and obstruction of CSF pathways. Fusion of skull base sutures can narrow the jugular foramina, compress venous sinuses, and create venous hypertension, which elevates intracranial pressure and impairs CSF absorption. Posterior fossa hypoplasia may contribute to crowding, downward displacement of the cerebellum, and secondary obstruction of CSF pathways. Airway obstruction and chronic hypoventilation in syndromic patients can further worsen venous congestion, increasing the risk of hydrocephalus. Q. What clinical features suggest craniosynostosis? Abnormal skull shape apparent at birth or early infancy Palpable ridging over a fused suture Facial asymmetry Orbital deformities such as harlequin eye, hypertelorism, hypotelorism Features of elevated ICP (irritability, vomiting, papilledema) Developmental delay in severe or syndromic forms Associated anomalies such as Chiari I, hydrocephalus, or airway obstruction in syndromic cases Q. What imaging modalities are used to diagnose craniosynostosis? Ultrasonography: ideal before 1 year; shows loss of suture gap and thickened suture margins X ray: may show sclerotic or absent suture and beaten copper appearance in severe ICP 3D CT: gold standard for defining fused sutures, cranial morphology, and surgical planning MRI: used when syndromic, for associated brain anomalies such as Chiari I or hydrocephalus MR or CT venography: required in syndromic cases with suspected venous anomalies Q. What is the role of MRI in craniosynostosis? MRI is particularly indicated in syndromic craniosynostosis and in lambdoid or bicoronal synostosis. It helps identify brain malformations, Chiari I, hydrocephalus, and dural anomalies. Newer techniques such as black bone MRI allow suture visualization without radiation exposure. It is also essential when planning cranial vault reconstruction in cases with venous anomalies. Q. How is craniosynostosis associated with Chiari I malformation? Premature fusion of lambdoid or skull base sutures reduces posterior fossa volume and may alter venous outflow, producing hindbrain crowding and tonsillar descent. Syndromic forms, particularly Crouzon and Pfeiffer syndromes, show high rates of Chiari I. Surgical correction of craniosynostosis often improves posterior fossa volume and may reverse tonsillar herniation. Q. How is nonsyndromic craniosynostosis managed? Management depends on suture involvement and severity of deformity: Repositioning therapy and physiotherapy for positional plagiocephaly Molding helmets for mild to moderate deformity Suturectomy or strip craniectomy in infants under 3 to 6 months Cranial vault remodeling for older infants or more complex deformities Early intervention optimizes cranial shape and reduces the risk of increased ICP. Q. What is endoscopic assisted craniosynostosis surgery? Endoscopic assisted suturectomy is performed before 6 months of age. It involves: A small incision over the fused suture Endoscopic strip craniectomy with removal of a 4 to 5 cm wide and approximately 11 cm long bone strip Lateral barrel stave osteotomies as needed Postoperative molding helmet therapy for 10 months Advantages include shorter surgery, less blood loss, minimal scarring, and excellent correction when performed early. Q. How is multisuture or syndromic craniosynostosis managed? These cases require early and aggressive surgical expansion due to severe intracranial volume restriction and high ICP risk. Management includes: Cranial vault expansion Frontoorbital advancement in coronal deformities Posterior cranial vault remodeling to address posterior fossa crowding or associated Chiari I Management of venous anomalies and hydrocephalus Children require multidisciplinary craniofacial care and long term monitoring. Q. What are the goals of surgery in craniosynostosis? The goals of surgery are to restore normal skull shape, increase intracranial volume, and prevent or treat elevated intracranial pressure. Surgery aims to normalize orbital and craniofacial anatomy, protect vision, relieve any venous or posterior fossa crowding, and allow symmetrical brain growth. In syndromic cases, surgery also supports airway function by improving midface and vault relationships and prevents long term neurodevelopmental impairment. OPEN SURGERY FOR CORONAL SYNOSTOSIS (Fronto Orbital Advancement) Positioning I will position the child supine with the head elevated on a padded head ring. I will turn the head slightly away from the side of the deformity in unilateral cases. I will ensure neutral neck alignment and avoid pressure on the eyes. I will shave minimally along the planned incision and infiltrate local anesthetic with adrenaline. Incision I will make a bicoronal incision from one tragus to the other, staying posterior to the hairline. I will bevel the incision anteriorly to allow hair to grow through the scar. I will elevate the scalp flap anteriorly in the subgaleal plane up to the orbital rims. Exposure I will identify the pericranium and create a separate pericranial flap for closure. I will elevate the scalp down to the superior orbital rims. I will identify the fronto zygomatic sutures and supraorbital nerves and protect them. I will expose the frontal bone, upper orbital rims, zygomaticofrontal processes, and fused coronal suture. Cranial and Orbital Osteotomies I will outline the fronto orbital bandeau with burr holes and connect them using a craniotome. I will remove the frontal bone flap in one or two pieces. I will then perform osteotomies along the superior orbital rims and lateral orbital walls to mobilize the fronto orbital bandeau as a single unit. Correction of Deformity I will reshape the bandeau on the back table to correct retrusion on the fused side and maintain symmetry. I will contour the orbital bar using greenstick bending or controlled osteotomies. I will then remodel the frontal bone flap to match the new orbital contour. I will ensure adequate anterior cranial vault expansion. Fixation I will secure the reconstructed bandeau to the skull using absorbable plates and sutures. I will place the remodeled frontal bone segments in an expanded and symmetric position. I will verify orbital symmetry, forehead projection, and smooth bone contour. Hemostasis and Duraplasty Considerations If dural pulsations are visible due to bone thinning, I will preserve the dura and ensure no injury. I will use bone dust or small bone grafts to fill gaps and prevent future deformities. Closure I will place a subgaleal drain if required. I will reapproximate the pericranium over the reconstructed vault. I will close the galea and skin in layers. I will apply a head wrap dressing to minimize swelling. Q. What are the principles of fronto orbital advancement? Fronto orbital advancement aims to correct deformities of the frontal bone and superior orbital rims caused by coronal synostosis. The principles include creating a fronto orbital bandeau through osteotomies that allow the orbital bar to be mobilized as a single unit, reshaping the bandeau to restore symmetric forehead and orbital projection, and expanding the anterior cranial vault. The remodeled bandeau is advanced anteriorly and fixed in a stable position with absorbable materials. The frontal bone flap is reshaped to match the new orbital contour, ensuring smooth transition and adequate intracranial volume expansion. OPEN SURGERY FOR SAGITTAL SYNOSTOSIS (Open Strip Craniectomy with Biparietal Expansion) Positioning I will position the infant prone or in a sphinx position depending on preference. The head will rest on a padded horseshoe headrest without pressure on the eyes. I will ensure neutral neck position and padding of all pressure points. I will shave a narrow strip along the intended incision. Incision I will make a midline sagittal incision from the anterior fontanelle to the posterior fontanelle, extending as needed toward the lambda. I will elevate the scalp flaps sub-galeally and protect emissary veins, especially in the posterior region. Exposure I will expose the fused sagittal suture, parietal bones, and both sides of the midline up to the temporoparietal junction. I will preserve the pericranium except where needed for burr holes. Strip Craniectomy I will create burr holes on both sides of the fused suture near the anterior and posterior fontanelles. I will use a craniotome to remove a strip of bone approximately 4 to 5 cm wide along the length of the sagittal suture. I will lift the fused bone strip carefully to avoid injury to the underlying dura and superior sagittal sinus. Barrel Stave Osteotomies I will perform radial barrel stave osteotomies on both parietal bones extending laterally toward the squamosal region. These cuts will allow outward expansion of the biparietal vault and correct the narrow skull shape. Vault Remodeling If significant deformity exists, I will remove additional parietal segments for contour remodeling. I will reshape and replace the parietal segments in a more lateral and expanded position to improve cranial width and reduce sagittal elongation. Fixation I will secure bone segments using absorbable sutures or plates. I will ensure symmetric biparietal expansion and adequate anterior posterior contour. I will verify dural pulsations and absence of compression. Hemostasis I will manage bleeding from emissary veins with bone wax and gentle pressure. I will inspect the dura and ensure no tears. Closure I will place a subgaleal drain only if necessary. I will close the galea and skin in layers. I will apply a head wrap dressing to minimize postoperative swelling. Q. What are the complications of craniosynostosis surgery? Blood loss requiring transfusion CSF leak Infection Dural injury Venous sinus injury in syndromic cases Incomplete correction requiring revision Residual or recurrent deformity Endoscopic approaches have significantly reduced morbidity and shortened recovery times. Q. What complications can occur in untreated craniosynostosis? Elevated intracranial pressure Developmental delay Optic nerve atrophy Respiratory obstruction in syndromic cases Progressive craniofacial deformity Chiari I malformation Venous hypertension Behavioral difficulties and headaches Q. What is the prognosis in craniosynostosis? With early surgical intervention, most nonsyndromic cases have excellent cosmetic and functional outcomes. Syndromic and multisuture synostosis may require multiple staged surgeries and have higher rates of increased ICP, Chiari I, visual impairment, and developmental delay. Long term follow up is essential for monitoring growth, ICP, vision, neurodevelopment, and airway issues.

Coming Soon.

Explore cranial neurosurgery with The Neurosurgical Case Room (TNCR) through structured video sessions and case-based discussions covering cranial anatomy, pathology, diagnosis and surgical management. Cranial Modules Adult Diffuse Gliomas Pediatric Diffuse Gliomas Hemangioblastoma Medulloblastomas Pilocytic Astrocytoma Meningiomas Ependymomas Brainstem Module Approaches to Ventricles Cranial Neurosurgical Approaches Pituitary Adenoma & EETS Sylvian Fissure Anatomy & Splitting

Review cervical laminectomy with concise neurosurgical notes covering indications, patient selection, surgical technique, fixation, complications, and outcomes. Cervical Laminectomy Q. What are the indications for cervical laminectomy? These are the indications: Multilevel cervical spondylotic myelopathy (CSM): Provided the patient has lordotic or neutral sagittal alignment. Multilevel OPLL or congenital canal stenosis: Especially when anterior options are limited by multi-segmental involvement. Intradural and intramedullary pathology: Providing direct posterior access for tumor resection or vascular lesion exposure. Focal radiculopathy: Performing a targeted hemilaminectomy or keyhole foraminotomy when lateral recess or foraminal stenosis is isolated to a single side. Q. What are the contraindications to cervical laminectomy? The contraindications include: Preoperative cervical kyphosis: Standalone laminectomy is contraindicated as it degrades the posterior tension band and worsens sagittal alignment. Fixed or flexible sagittal deformity: Better addressed via anterior or combined deformity correction approaches. Frank or potential segmental instability: Spondylolisthesis or hypermobility require stabilization. Need for extensive facetectomy: Cases requiring >50% facet resection without concurrent fusion. Q. What are the types of cervical laminectomy, and when is each used? Standard Multilevel Laminectomy: Bilateral troughing with en bloc lamina elevation; used for generalized central canal stenosis and multilevel myelopathy. Laminectomy with Instrumentated Fusion: Chosen when there is underlying instability, kyphotic drive, or when extensive facet resection is needed. Hemilaminectomy / Laminotomy with Foraminotomy: Targeted unilateral decompression for single-level root compression or lateral recess disease, preserving contralateral musculature and bone. Keyhole Minimally Invasive Laminotomy: Indicated for focal foraminal disc herniations or single-level lateral recess pathology in well-aligned spines. Q. When should you add fusion after laminectomy? I add fusion in the following scenarios: Preoperative cervical alignment is kyphotic or cannot be maintained in lordosis intraoperatively. Segmental instability is present preoperatively or created iatrogenically during decompression. Facetectomy approaches or exceeds 50% of a facet complex at any given level. Multilevel decompression is performed in high-risk populations for postlaminectomy kyphosis (e.g., pediatric patients, young adults, or those with baseline connective tissue disease). Q. What benefits does laminectomy offer compared with laminoplasty, and vice versa? Laminectomy: Provides wide, direct posterior exposure ideal for intradural tumors, permits easy incorporation of lateral mass instrumentation when fusion is required, and eliminates any risk of hinge re-closure. However, un-fused cases carry a higher rate of late kyphotic deformity and axial neck pain. Laminoplasty: Preserves segmental spinal motion, maintains the structural posterior arch, avoids pseudarthrosis risks, and rarely requires rigid postoperative immobilization. Downsides include risk of hinge fracture or re-closure, higher rates of persistent axial neck pain, potential C5 nerve root palsy, and unsuitability for intradural tumor resection or kyphotic spines. Q. How will you perform cervical laminectomy? Positioning & Exposure: I position the patient prone using a Mayfield 3-pin clamp in neutral or slight extension, pad all pressure points, and prep/drape widely. I make a midline posterior incision and perform subperiosteal dissection out to the lamina–facet junctions, taking care to preserve the facet capsules and the muscular attachments at C2 and C7. Trough Creation: I remove interspinous ligaments at the cranial and caudal limits. Using a high-speed burr, I construct bilateral troughs at the lamina–facet junctions, angling the burr 30 - 45 degrees relative to the spinous process to stay perpendicular to the laminar cortices. I thin down to the inner cortex bilaterally. Elevating the Lamina: I carefully release the remaining inner cortex with a 1-mm Kerrison or curette and divide the ligamentum flavum at the margins. Using towel clips on the spinous process for control, I gently elevate the laminar sheet en bloc, dissecting away any dural adhesions underneath. Decompression & Closure: I perform additional bone removal with 1–2 mm Kerrisons as needed, complete planned foraminotomies without compromising >50% of the facet, confirm complete dural expansion, achieve meticulous hemostasis, place a subfascial drain, and perform a robust layered closure of the nuchal fascia to reconstruct the posterior tension band. Q. What implants are used with laminectomy if stabilization is required? If stability is a concern, I will add posterior instrumentation: lateral mass screws (C3–C6), pedicle or pars screws where appropriate, connected with rods. Graft options include local autograft, iliac crest autograft, or allograft as per exposure and need. Q. What are the complications and pitfalls of cervical laminectomy? Postlaminectomy kyphosis (risk higher in children and in those with pre-existing deformity), axial neck pain, epidural hematoma, infection, dural tear/CSF leak, C5 palsy, inadequate decompression, and iatrogenic instability (especially with excessive facet resection). Technical pitfalls include making the laminectomy trough too wide (bleeding from venous plexus) or too narrow (leaving residual stenosis), failing to remove bordering flavum before lifting the lamina, and poor fascial closure leading to wound problems. Postoperative Care and Rehabilitation Q. How will you manage the patient postoperatively after cervical laminectomy? I will monitor neurologic status, drain output, and wound. A soft collar may be used for comfort for 1–2 weeks in stable cases; immobilization is individualized when fusion or instability is present. Early signs of C5 palsy or hematoma will be watched closely. Q. When will you start mobilization and physiotherapy? I will begin sitting and ambulation on postoperative day 1. Shoulder range-of-motion begins early; neck range is advanced gradually as pain allows. If fusion was added, activity restrictions follow the fusion protocol. Q. What activity restrictions and follow-up are advised? I will limit heavy lifting and abrupt neck movements for 4–6 weeks. Driving is avoided during this period. Follow-up radiographs at 4–6 weeks assess alignment and, if fused, hardware position; MRI is obtained for new deficits or plateaued recovery. Children and patients with preoperative deformity require particular surveillance for postlaminectomy kyphosis. Q. Why is C5 palsy a specific complication of cervical laminectomy and posterior decompression? A. C5 palsy, manifesting as postoperative weakness of the deltoid and/or biceps muscles, is a recognized complication following posterior cervical decompression, primarily due to tethering of the nerve root secondary to posterior drift of the spinal cord. The main mechanisms and risk factors include: Posterior Cord Drift (Tethering Effect): Once the constraining posterior arch and ligamentum flavum are removed, the decompressed spinal cord drifts posteriorly away from anterior compressive elements (such as osteophytes or OPLL). Because the C5 nerve root is structurally short, relatively fixed at the neural foramen, and exits at the apex of the cervical lordosis, posterior displacement of the cord places direct traction and mechanical strain on the root. Ischemic / Reperfusion Injury: Rapid decompression of a chronically compressed spinal cord can alter local microvascular perfusion, leading to transient reperfusion injury or focal ischemia at the C5 segment or root entry zone. Intraoperative Root Trauma: Heat generated from high-speed burring during trough creation near the C5 foramen, or direct mechanical irritation from Kerrison punch placement during foraminotomy, can cause focal nerve dysfunction. While C5 palsy is usually temporary and resolves with conservative management and physical therapy over 6 to 18 months, prevention strategies include avoiding excessive lordotic correction, performing gentle, targeted foraminotomies, and minimizing thermal transfer during trough drilling.

Explore split cord malformation with The Neurosurgical Case Room (TNCR), including embryology, classification, clinical presentation, imaging, associated anomalies and principles of surgical management. Split Cord Malformation Q. What is a split cord malformation? A split cord malformation is a congenital spinal dysraphism in which the spinal cord is longitudinally divided into two hemicords, each containing its own dorsal and ventral nerve roots and central canal. The split is produced by a persistent abnormal midline tract composed of mesenchymal, endodermal, or ectodermal tissue, which physically divides the neural tube. SCM is strongly associated with tethered cord syndrome and progressive neurological deterioration. Q. How are split cord malformations classified? SCM is divided into two main types: Type I SCM: The hemicords lie in separate dural sacs, separated by a rigid osseocartilaginous septum. The septum is typically anchored to the vertebral body and creates fixed tethering. Type II SCM: Both hemicords lie in a single dural sac, separated by a non-rigid fibrous septum. The tethering effect is generally less severe than in Type I. Type I tends to cause earlier and more significant symptoms because the bony spur acts as a fixed mechanical tether. Q. What is the embryological basis of split cord malformations? SCM arises from formation of an accessory neurenteric canal early in development. This abnormal tract allows ectoderm, mesoderm, and endoderm to mix. Mesenchyme condenses along this tract, forming a persistent midline structure that differentiates into either bone/cartilage (Type I) or fibrous tissue (Type II). If the abnormal tract splits the forming dura early, two dural sacs develop; if late or incomplete, a single sac remains. Q. Why is scoliosis common in SCM? Scoliosis develops due to chronic asymmetrical tethering forces acting on the hemicords. The distorted pull on the neuroaxis during growth produces progressive curve formation. Scoliosis may be the presenting feature and should always prompt MRI evaluation for SCM. Q. What are the indications for surgery in SCM? Surgery is indicated for: Progressive neurological deficits Orthopedic deformity progression (scoliosis, foot deformity) Urological deterioration Presence of a rigid midline septum producing fixed tethering Associated lesions with high risk, such as dermal sinus tract Symptomatic tethered cord regardless of type Type I SCM is generally treated earlier because the rigid septum always produces tethering. Q. What is diastematomyelia? Diastematomyelia is the classical form of Type I Split Cord Malformation, in which the spinal cord is divided into two hemicords by a rigid osseous or cartilaginous septum. The two hemicords lie in separate dural tubes. The septum is usually anchored to the vertebral body, producing a fixed tethering effect. Q. What is the embryological mechanism behind diastematomyelia? It results from early formation of an accessory neurenteric canal, allowing mesenchymal tissue to migrate into the midline and form an osseocartilaginous spur. Because this occurs early in dural development, the dura splits into two separate sacs. Q. What clinical features suggest diastematomyelia? Children usually present with: Progressive scoliosis Neurological deterioration: weakness, gait abnormalities Sensory deficits Foot deformities (cavovarus, clubfoot) Orthopedic asymmetry (limb-length difference) Urological dysfunction Skin findings such as hairy patches, dermal sinuses, lipomas, dimples, or angiomas frequently overly the defect. Q. What imaging features characterize diastematomyelia? MRI shows two hemicords in separate dural sacs with a midline septum. CT is essential for defining the bony spur. Often associated with vertebral anomalies including hemivertebra or block vertebra. Q. What complications are seen in diastematomyelia surgery? Risks include neural injury, root damage, CSF leak, pseudomeningocele, infection, residual septum causing retethering, and postoperative deformity progression. Q. What is the prognosis for diastematomyelia? Early surgery before severe neurological decline provides the best outcomes. Type I SCMs have a higher retethering risk due to the rigid spur and separate dural sacs. Q. What is diplomyelia? Diplomyelia is a true duplication of the spinal cord, where two complete spinal cords exist side-by-side, each surrounded by its own pia and typically enclosed in a single dural sac. Unlike diastematomyelia, there is no bony or fibrous septum splitting the canal. Q. How is diplomyelia different from diastematomyelia? Diplomyelia: true duplication of the spinal cord, two cords develop independently, usually in a single dural sac, no septum. Diastematomyelia: one cord split into two hemicords by a septum with two dural sacs (Type I SCM). Diplomyelia is extremely rare compared to diastematomyelia. Q. What is the embryological basis of diplomyelia? It likely results from complete duplication of the notochord or neural plate during early gastrulation, unlike SCM Type I which stems from an accessory neurenteric canal and septum formation. Q. How does diplomyelia present clinically? Symptoms resemble tethered cord: gait disturbance, weakness, sensory changes, scoliosis, orthopedic deformities, and bladder dysfunction. Skin markers may be present but are less consistent than in diastematomyelia. Q. What does MRI show in diplomyelia? MRI shows two fully formed cords without a septum and usually within one dural sac. No bony spur is seen. Associated anomalies may include tethered cord, dermoid, lipoma, or segmentation abnormalities. Q. How is diplomyelia treated? Surgery aims to de-tether the cord, release any adhesions, and perform duraplasty. Because there is no bony spur to remove, surgery focuses on freeing the cords from tethering bands and reconstructing a capacious dural sac. Care must be taken not to confuse duplicated cords with roots or placode. Q. What is the prognosis of diplomyelia? Generally depends on associated anomalies and extent of tethering. Outcomes are better than in diastematomyelia because no rigid septum is present. Long-term follow-up is essential due to risk of retethering. Surgical Steps for Split Cord Malformation: I will position the child prone with careful padding of all pressure points and mark the midline over the suspected split cord level. After a wide antiseptic preparation and draping, I will make a midline incision and expose the posterior elements of the spine. I will perform a laminectomy or laminotomy spanning the entire cranio-caudal extent of the split so that both the septum and both hemicords are fully accessible. I will remove only the minimum bone needed to avoid postoperative instability while still ensuring complete visualization of the midline spur and the dural sleeves. Under the operating microscope, I will open the dura longitudinally. In Type I split cord malformation, I will encounter two separate dural sacs, each containing a hemicord. I will open each dural tube along its length and tack the margins laterally to maintain exposure. I will then identify the rigid osseous or cartilaginous septum that divides the canal. This septum is often attached deeply to the posterior vertebral body, so I will carefully dissect around it circumferentially to define its margins. Using a high-speed drill, fine osteotomes, or micro-rongeurs, I will remove the septum completely from dorsal to ventral, ensuring that the entire bony anchor at its base is eliminated. I will work slowly and precisely to avoid injury to the hemicords and their exiting roots, which may course very close to the septum. In Type II split cord malformation, I will find both hemicords within a single dural sac, separated by a fibrous band. In this situation, I will sharply dissect the fibrous septum away from the neural tissue, cutting it completely to release the abnormal tethering connection. I will also look for additional tethering structures such as arachnoidal adhesions, fibrofatty bands, or thickened filum components, and I will divide these carefully to ensure the hemicords are entirely free. After removing the septum in Type I or releasing the fibrous band in Type II, I will inspect the conus and both hemicords to ensure they move freely without fixed points. I will then create a single, capacious dural sac for both hemicords. In Type I, this requires unifying the two dural sleeves by incising their medial walls and reconstructing one large dural space. I will perform a generous duraplasty using autologous fascia or a synthetic graft to prevent postoperative retethering and to allow the neural elements enough room for physiological movement. I will close the dura in a watertight fashion with fine sutures, ensuring no leaks or tension points remain. Once the dura is closed, I will close muscle, fascia, subcutaneous tissue, and skin in layered fashion, taking care to avoid tension that might compromise wound healing. I will maintain meticulous hemostasis and confirm that the reconstructed canal has no compressive elements remaining. Postoperatively, I will monitor neurological function, bladder status, and wound integrity, and arrange follow-up imaging to assess the adequacy of detethering and exclude retethering or postoperative complications.

Dr. Kanwal Ali Qambrani is a consultant neurosurgeon and founder of The Neurosurgical Case Room (TNCR), a global, open-access platform for neurosurgical learning. ABOUT THE FOUNDER Dr. Kanwal Ali Qambrani MBBS, FCPS Neurosurgery Founder, The Neurosurgical Case Room Consultant Neurosurgeon Indus Medical College Hospital, Pakistan Dr. Kanwal Ali Qambrani is a neurosurgeon from Hyderabad, Sindh, Pakistan, and TNCR began with a problem she knew firsthand. Training in neurosurgery meant navigating an enormous body of knowledge within an equally demanding schedule. The knowledge was there, but it was scattered, rarely structured as a curriculum, seldom easy to navigate, and never equally accessible to everyone. That experience stayed with her. As she grew as a surgeon, so did a simple idea: what if neurosurgical knowledge could travel further than the opportunities available to an individual trainee? What if complex subjects could be taught systematically, made easier to absorb, and, most importantly, translated into better decisions and greater competence in the operating room? That idea, born in Hyderabad, became The Neurosurgical Case Room. For Dr. Qambrani, TNCR is ultimately about giving back in two directions. To the neurosurgical community, by making high-quality, structured education accessible regardless of geography or resources. And to patients, by helping that education travel the final, and most important lag, the distance: from knowledge to surgical competence, and from surgical competence to better care. TNCR is her attempt to build something that outlives an individual lecture, course, or career: a growing body of neurosurgical education that can be learned from anywhere, carried into the operating room, and passed forward.

Explore Sylvian fissure anatomy and splitting with The Neurosurgical Case Room (TNCR), covering microsurgical anatomy, vascular relationships, dissection technique and operative principles. Sylvian Fissure Anatomy & Splitting Sylvian Fissure Anatomy Part 1 A detailed overview of the microsurgical anatomy and initial orientation required for a successful Sylvian fissure split. Understanding the surface landmarks and vascular relationships is critical before beginning the dissection. Sylvian Fissure Anatomy Part 2 Build on your understanding of the Sylvian Fissure in this focused Part 2 session, designed to simplify microsurgical anatomy and dissection concepts. Sylvian Fissure Splitting Master Sylvian fissure splitting with a clear, step-by-step approach designed for neurosurgery residents and trainees. This video breaks down microsurgical anatomy, safe dissection planes, arachnoid opening techniques, and key operative landmarks essential for pterional and transsylvian approaches.

Explore intracranial fungal granuloma with The Neurosurgical Case Room (TNCR), including clinical presentation, imaging, diagnosis and principles of medical and surgical management. Intracranial Fungal Granuloma Q. What is an intracranial fungal granuloma? It is a localized chronic granulomatous infection of the brain or meninges caused by fungal organisms. The lesion forms due to a delayed hypersensitivity response with central necrosis and peripheral granulomatous reaction, often mimicking tuberculoma or neoplasm. It may involve brain parenchyma, meninges, or skull base, and is usually secondary to contiguous spread from paranasal sinuses. Q. What is its epidemiology and incidence? Intracranial fungal granulomas are more common in tropical and subtropical regions such as South and Southeast Asia. They typically occur in immunocompromised patients, i.e. those with diabetes mellitus, prolonged corticosteroid use, HIV/AIDS, malignancy, or chemotherapy. The most frequent organisms are Aspergillus species and Mucorales (Mucor, Rhizopus). CNS involvement is seen in about 10–20% of disseminated fungal infections. Rarely, fungal granulomas can occur in immunocompetent individuals, especially after chronic sinusitis. Q. What are the causative organisms and pathological features? A. Pathogenic fungi (can infect immunocompetent hosts): - Cryptococcus neoformans - Histoplasma capsulatum - Coccidioides immitis - Blastomyces dermatitidis - Paracoccidioides brasiliensis - Sporothrix schenckii B. Opportunistic fungi (in immunocompromised hosts): - Aspergillus fumigatus, A. flavus, A. niger - Mucorales: Mucor, Rhizopus, Absidia - Candida albicans - Phaeohyphomycosis (dematiaceous fungi) Histopathology: Granulomatous inflammation with central necrosis, epithelioid and giant cells, and fungal hyphae visible on PAS or GMS stain. Aspergillus shows acute-angle (45°), septate branching hyphae with angioinvasion and thrombosis. Mucor shows broad, non-septate right-angle branching hyphae. Angioinvasion leads to infarction, hemorrhage, and necrosis. Q. Which sites are commonly affected? - Frontal and temporal lobes by extension from paranasal sinuses (especially sphenoid and ethmoid). - Cavernous sinus, orbit, and skull base. - Cerebellum in hematogenous spread. - Basal cisterns and vascular structures are frequently invaded by Aspergillus. - Rhinocerebral mucormycosis often begins in nasal cavity and spreads via ethmoid sinuses into the orbit and frontal lobe. Q. What are the usual clinical features? - Persistent headache and vomiting due to raised intracranial pressure. - Focal deficits depending on site: hemiparesis, aphasia, cranial nerve palsy. - Seizures, altered sensorium, or proptosis in cases with orbital extension. - Cavernous sinus involvement causes ophthalmoplegia, ptosis, and facial numbness. - Often presents as a space-occupying lesion unresponsive to antibiotics or anti-tuberculous therapy. - Systemic features include fever, sinus discharge, or signs of chronic sinusitis. Q. What are the characteristic radiologic features? CT Scan: - Iso- to hyperdense lesion with irregular margins and surrounding edema. - May show calcifications or bone erosion in skull base involvement. - Variable ring or nodular enhancement after contrast. MRI: - T1: Iso- to hypointense core. - T2: Marked hypointensity due to iron and manganese within fungal elements. - Post-contrast: Peripheral or irregular ring enhancement. - DWI: May show restricted diffusion when abscess is present. - MR Spectroscopy: Lipid–lactate peaks with absent amino acid peaks (helps differentiate from pyogenic abscess). - Sinus disease and orbital or vascular invasion are often visible. T2 hypointensity with irregular ring enhancement is a characteristic feature of fungal granuloma. MR Angiography/CT Angiography: Essential to evaluate vascular encasement, arterial occlusion, or mycotic pseudoaneurysm formation (due to fungal angioinvasion). Q. What are the important differential diagnoses? - Tuberculoma - Pyogenic brain abscess - Neurocysticercosis (granular–nodular stage) - High-grade glioma or metastasis - Sarcoidosis or parasitic granuloma Q. How will you manage a case of intracranial fungal granuloma? A. Preoperative work-up: - MRI brain with contrast ± MR angiography - CT paranasal sinuses to identify the primary source - Nasal endoscopy for diagnostic biopsy - Routine hematologic tests and glycemic control - Fungal culture, KOH mount, and histopathologic confirmation via nasal biopsy if sinus involvement is present - Systemic Optimization: Urgent glycemic control (HbA1c/blood sugar), reversal of ketoacidosis, reduction of systemic steroids/immunosuppression, and baseline renal/hepatic profiling B. Surgical Management Indications: - Space-occupying lesion with mass effect. - Diagnostic uncertainty. - Failure of medical therapy or presence of abscess cavity. C. Surgical Goals: Achieve maximum safe resection and decompression. Obtain specimen for diagnosis. Control primary source if sinus or skull base involvement exists. D. Surgical Corridors: Anterior Skull Base / Cavernous Sinus: Frontotemporal, subfrontal, or cranio-orbitozygomatic (COZ) approach; or expanded endoscopic endonasal approach (EEA) for midline clival/sphenoid lesions. Posterior Fossa: Retrosigmoid or far-lateral approach depending on location. E. Operative Strategy & Pitfalls: Firm & Adherent Lesion: Granulomas are notoriously avascular/fibrotic center-wise but extremely adherent peripherally. Avoid Radical Capsule Traction: Fungi are highly angioinvasive. Encased major arteries (e.g., ICA, MCA, ACoA) become brittle and prone to intraoperative avulsion or postoperative stroke. Perform piecemeal internal debulking rather than en bloc resection when major vessels are involved. Irrigation: Copious irrigation with warm normal saline. Note: Intrathecal or local intraoperative Amphotericin B irrigation is controversial and generally avoided due to chemical arachnoiditis/neurotoxicity risks. Closure: Watertight dural repair (graft if needed) to prevent CSF leak and secondary bacterial meningitis. Postoperative Care: - Early initiation of systemic antifungal therapy. - Monitor renal and hepatic function regularly. - Control diabetes and immune suppression. Medical Therapy: General Principles: - Start systemic antifungal therapy immediately after diagnosis or biopsy. - Continue for at least 6–12 weeks or until complete clinical and radiological resolution. - Choose antifungal according to causative organism, site, and host immune status. 1. Aspergillosis (CNS Aspergilloma / Granuloma) - First-line drug: Voriconazole - Loading: 6 mg/kg IV every 12 h for 2 doses. - Maintenance: 4 mg/kg IV every 12 h or 200 mg PO q12 h. - Duration: Minimum 6–12 weeks (oral continuation up to 3–6 months). - Alternative: Liposomal Amphotericin B 3–5 mg/kg/day IV. - Resistant cases: Posaconazole 300 mg PO daily (after 300 mg BID on day 1) or Caspofungin 50 mg IV daily as adjunct. - Adjunctive therapy: Endoscopic sinus clearance if paranasal source present. 2. Mucormycosis (Rhinocerebral / Skull Base Form) - First-line: Liposomal Amphotericin B 5–10 mg/kg/day IV. - Conventional Amphotericin B deoxycholate 1 mg/kg/day if liposomal not available. - Step-down / maintenance: - Posaconazole 300 mg PO daily (after 300 mg BID day 1) - or Isavuconazole 200 mg IV/PO TDS for 48 h, then 200 mg daily. - Duration: At least 12 weeks; longer if sinus invasion persists. - Adjuncts: Surgical debridement of necrotic tissue, control of diabetes, cessation of steroids, and correction of acidosis. 3. Candida (Cerebral Candidiasis / Abscess) - First-line: Liposomal Amphotericin B 5 mg/kg/day IV ± Flucytosine 25 mg/kg q6 h PO. - Step-down: Fluconazole 400–800 mg/day PO or IV once improved. - Duration: 6–8 weeks minimum. Drain large or multiloculated abscesses surgically. 4. Cryptococcus (Cryptococcal Meningoencephalitis / Granuloma) - Induction (2 weeks): Amphotericin B 1 mg/kg/day + Flucytosine 25 mg/kg q6 h. - Consolidation: Fluconazole 400–800 mg/day PO for 8 weeks. - Maintenance: Fluconazole 200 mg/day PO for 6–12 months, especially in HIV-positive patients. - Adjunct: Manage raised ICP by CSF drainage if needed. 5. Dematiaceous (Phaeohyphomycosis and other rare fungi) - Voriconazole 200 mg PO q12 h or Posaconazole 300 mg PO daily preferred. - Duration: ≥ 6 months, often prolonged due to frequent relapse. Monitoring and Supportive Care: - Check renal and hepatic functions twice weekly during amphotericin therapy. - Maintain serum potassium > 3.5 mmol/L and magnesium > 1.8 mg/dL. - Avoid concomitant nephrotoxic drugs. - Monitor drug levels for voriconazole (trough 1–5 µg/mL). - Control underlying systemic disease (diabetes, immunosuppression). Q. What are the possible complications? - Postoperative hemorrhage or infarction from angioinvasion. - Meningitis or CSF leak. - Hydrocephalus. - Renal toxicity from amphotericin. - Recurrent infection from untreated sinus or orbital focus. Q. What is the prognosis? Mortality remains high, ranging from 25–40% in angioinvasive aspergillosis and mucormycosis. Favorable prognosis depends on: - Early diagnosis and prompt initiation of antifungal therapy. - Complete surgical excision where feasible. - Control of systemic risk factors. - Immunocompetent status of the patient. Q. What is the follow-up protocol? - MRI brain every 3 months during the first year, then every 6 months. - Monitor renal and hepatic parameters during therapy. - Repeat sinus evaluation to rule out recurrent infection. - Long-term oral antifungal prophylaxis in persistent immunocompromise. Recalls: - Most common agents: Aspergillus and Mucor. - Classic MRI finding: T2 hypointense core with irregular ring enhancement. - Confirm diagnosis by biopsy before starting therapy. - Voriconazole is the drug of choice for CNS aspergillosis. - Liposomal Amphotericin B (5–10 mg/kg/day) is preferred for mucormycosis. - Combined surgery and antifungal therapy give the best outcomes. - Early sinus debridement prevents recurrence and intracranial extension.

Explore hemangioblastoma with The Neurosurgical Case Room (TNCR), including clinical presentation, imaging, association with VHL disease, surgical planning and principles of management. Hemangioblastomas In this session of The Neurosurgical Case Room, we discuss the radiologic hallmarks, clinical presentation, vascular considerations, and decision-making in hemangioblastoma. In this session of The Neurosurgical Case Room, we focus on the management and operative strategy for hemangioblastoma, one of the most vascular tumors encountered in posterior fossa surgery. The discussion centers on surgical planning, approach selection, and the principle of en bloc resection to prevent uncontrolled bleeding. Key nuances such as preservation of venous drainage, sequential control of arterial feeders, and avoidance of internal debulking are emphasized. We also address decision-making in cerebellar lesions and the clinical context of Von Hippel–Lindau disease.

Explore ependymomas with The Neurosurgical Case Room (TNCR), including classification, molecular features, clinical presentation, imaging and principles of neurosurgical management. Ependymomas - A Master Class Ependymoma | Basics This session on Ependymomas covers their clinical presentation, radiologic features, molecular classification, and surgical considerations, discussed through real neurosurgical cases. The discussion emphasizes anatomic and biologic differences across supratentorial, posterior fossa, and spinal ependymomas, highlighting how tumor location and molecular subtype influence prognosis, surgical strategy, and adjuvant treatment decisions. Posterior Fossa Ependymomas This session on Posterior Fossa Ependymomas examines their clinical presentation, radiologic features, molecular subgroups, and surgical considerations, discussed through real neurosurgical cases. The discussion emphasizes anatomic relationships to the brainstem and cranial nerves, common imaging pitfalls, and how tumor location and biology influence extent of resection, prognosis, and adjuvant therapy. Spinal Ependymomas This session on Spinal Ependymomas focuses on their clinical presentation, imaging features, and surgical management, discussed through real neurosurgical cases. The discussion highlights key anatomic considerations, tumor–cord relationships, extent of resection, and postoperative outcomes, with emphasis on how these factors influence neurologic preservation and long-term prognosis. Myxopapillary Ependymoma & Subependymoma This session covers Myxopapillary Ependymoma and Subependymoma, highlighting their distinct anatomic locations, imaging features, and surgical considerations, discussed in a concise manner. The discussion emphasizes tumor behavior, extent of resection, recurrence risk, and long-term outcomes, with a focus on how these typically indolent ependymal tumors differ from other spinal and intracranial neoplasms.